Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Clin Invest ; 63(5): 1006-14, 1979 May.
Article in English | MEDLINE | ID: mdl-447822

ABSTRACT

Because human platelets participate in the contact phase of intrinsic coagulation and contain a Factor XI-like coagulant activity, the nature of the Factor XI-like activity was examined and compared with purified plasma Factor XI. The platelet factor XI-like activity was sedimented with the particulate fraction of a platelet lysate, was inactivated by heat (t(1/2) 3.5 min, 56 degrees C), was not a nonspecific phospholipid activity, and was destroyed by treatment with Triton X-100. Isolated platelet membranes were four-fold enriched in Factor XI activity and similarly enriched in plasma membrane marker enzymes. The Factor XI-like activity of platelet membranes was detected only when assayed in the presence of kaolin, which suggests that it is present in an unactivated form and can participate in contact activation. Concanavalin A inhibited the Factor XI-like activity of platelet lysates and platelet membranes but not of plasma or purified Factor XI. A platelet membrane-Factor XI complex was isolated after incubation of membranes with purified Factor XI. The Factor XI activity of the platelet membrane-plasma Factor XI complex was inhibited by concanavalin A, whereas unbound plasma Factor XI retained activity. An antibody raised against plasma Factor XI inhibited the in vitro Factor XI activity of plasma and of the platelet membrane-plasma Factor XI complex but had no effect on the endogenous Factor XI-like activity of washed lysed platelets or isolated platelet membranes. Washed platelets and isolated platelet membranes obtained from a Factor XI-deficient donor without a history of excessive bleeding had normal quantities of platelet Factor XI-like activity and normal behavior in the contact phase of coagulation (collagen-induced coagulant activity). These results indicate that platelet membranes contain an endogenous Factor XI-like activity that is functionally distinct from plasma Factor XI.


Subject(s)
Blood Platelets/metabolism , Factor XI/metabolism , Antibodies , Blood Coagulation Tests , Blood Platelets/enzymology , Cell Fractionation , Cell Membrane/enzymology , Cell Membrane/metabolism , Collagen/pharmacology , Concanavalin A/pharmacology , Factor XI/antagonists & inhibitors , Factor XI/immunology , Factor XI Deficiency/blood , Humans
2.
J Biol Chem ; 251(11): 3261-8, 1976 Jun 10.
Article in English | MEDLINE | ID: mdl-931986

ABSTRACT

Human tryptophanyl-tRNA synthetase resembles its counterpart in Escherichia coli in quaternary structure (alpha2), but differs in molecular weight, amino acid composition, the number of thiol groups, and the relationship of the thiol groups to enzyme activity. Nevertheless, one of the thiol groups resides in a heptapeptide sequence homologous to a heptapeptide sequence containing a thiol group in the E. coli enzyme. Each subunit of the enzyme has 6 half-cystine residues, and four thiol groups are readily titrated with 5,5'-dithiobis(2-nitrobenzoic acid). Titration of these four thiol groups inactivates the enzyme, and the inactivation is partially reversible by reduction with dithiothreitol. One thiol group reacts rapidly unless L-tryptophan, ATP, and Mg2+ are present together.


Subject(s)
Amino Acyl-tRNA Synthetases , Tryptophan-tRNA Ligase , Adenosine Triphosphate , Amino Acid Sequence , Amino Acids/analysis , Amino Acyl-tRNA Synthetases/metabolism , Binding Sites , Dithionitrobenzoic Acid , Dithiothreitol , Humans , Iodoacetates , Kinetics , Macromolecular Substances , Magnesium , Molecular Weight , Peptide Fragments/analysis , Protein Binding , Protein Conformation , Sulfhydryl Compounds/analysis , Tryptophan , Tryptophan-tRNA Ligase/isolation & purification , Tryptophan-tRNA Ligase/metabolism
3.
Br J Haematol ; 33(1): 9-18, 1976 May.
Article in English | MEDLINE | ID: mdl-1268092

ABSTRACT

The coagulant activities of various phospholipid preparations were compared with those of platelets. Folch phospholipid with maximal platelet factor 3 (PF3) activity produced long recalcified clotting times of relatively undiluted plasma in plastic tubes whereas untreated or ADP-treated platelets with minimal PF3 activity produced short clotting times in the same test system which is sensitive to activators of the contact system of intrinsic coagulation. Bell and Alton phospholipids with maximal PF3 activity produced recalcified clotting times similar to those in the presence of platelets. Bell and Alton phospholipids had tissue factor activity, but Folch phospholipid and platelets did not. Bell and Alton phospholipids and gum acacia (used as a vehicle in one of the preparations) activated factor XII as did platelets, but Folch phospholipid did not. The multiple coagulant activities of Bell and Alton phospholipids (i.e. PF3, tissue factor and contact activating) may account for the absence of coagulant superiority of platelets in the undiluted system in plastic tubes. The coagulant activities of platelets are also complex but different from Bell and Alton phospholipids whereas Folch phospholipid would appear to possess only PF3 activity.


Subject(s)
Blood Coagulation , Blood Platelets/physiology , Phospholipids/physiology , Blood Coagulation/drug effects , Blood Coagulation Tests , Factor XII/metabolism , Humans , In Vitro Techniques , Phospholipids/pharmacology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...